Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH Recall
Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH, Model Number: CDS860014P; 2) IV START KIT, Model Number: DYKM1000B; 3) KIT, I V START NSK, Model Number: DYKM2187; 4) KIT, I V START NSK, Model Number: DYKM2187A; 5) IV BLOOD CULTURE KIT, Model Number: DYNDH1909A; 6) IV START W/EXT SET KIT, Model Number: DYNDV1615I
FDA recall Class II
Ongoing
FDA lists this Class II recall for Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-3056-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jun 12, 2026
- FDA report date
- Sep 9, 2026
- Quantity in commerce
- 22736 Kits
- Distribution
- See key details
- FDA cause
- Nonconforming Material/Component
What is being recalled?
Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH, Model Number: CDS860014P; 2) IV START KIT, Model Number: DYKM1000B; 3) KIT, I V START NSK, Model Number: DYKM2187; 4) KIT, I V START NSK, Model Number: DYKM2187A; 5) IV BLOOD CULTURE KIT, Model Number: DYNDH1909A; 6) IV START W/EXT SET KIT, Model Number: DYNDV1615I
Affected model & UDI checker
Search the exact identifiers published for Z-3056-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| CDS860014P | Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH | Check source notice | Not specified |
| DYKM1000B | Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH | Check source notice | Not specified |
| DYKM2187 | Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH | Check source notice | Not specified |
| DYKM2187A | Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH | Check source notice | Not specified |
| DYNDH1909A | Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH | Check source notice | Not specified |
| DYNDV1615I | Medline Convenience Kits: 1) IV START KIT LAB DRAW-SH | Check source notice | Not specified |
FDA code information
1) CDS860014P, UDI-DI: 10888277797819(each), 40888277797810(case), Lot Number: 25DBN710; 2) CDS860014P, UDI-DI: 10888277797819(each), 40888277797810(case), Lot Number: 24BBH722; 3) CDS860014P, UDI-DI: 10888277797819(each), 40888277797810(case), Lot Number: 24CBV460; 4) CDS860014P, UDI-DI: 10888277797819(each), 40888277797810(case), Lot Number: 24EBR549; 5) CDS860014P, UDI-DI: 10888277797819(each), 40888277797810(case), Lot Number: 24GBH769; 6) CDS860014P, UDI-DI: 10888277797819(each), 40888277797810(case), Lot Number: 23KBN939; 7) CDS860014P, UDI-DI: 10888277797819(each), 40888277797810(case), Lot Number: 23LBT913; 8) DYKM1000B, UDI-DI: 10889942508143(each), 40889942508144(case), Lot Number: 24AMB256; 9) DYKM1000B, UDI-DI: 10889942508143(each), 40889942508144(case), Lot Number: 24BMF851; 10) DYKM1000B, UDI-DI: 10889942508143(each), 40889942508144(case), Lot Number: 24DMC055; 11) DYKM1000B, UDI-DI: 10889942508143(each), 40889942508144(case), Lot Number: 24FMB552; 12) DYKM1000B, UDI-DI: 10889942508143(each), 40889942508144(case), Lot Number: 24IMF355; 13) DYKM1000B, UDI-DI: 10889942508143(each), 40889942508144(case), Lot Number: 24KMD782; 14) DYKM1000B, UDI-DI: 10889942508143(each), 40889942508144(case), Lot Number: 23IMI364; 15) DYKM1000B, UDI-DI: 10889942508143(each), 40889942508144(case), Lot Number: 23JMG372; 16) DYKM2187, UDI-DI: 10195327232924(each), 40195327232925(case), Lot Number: 23JBQ286; 17) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 25ABI946; 18) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 25ABV328; 19) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 24LBM058; 20) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 24LBO554; 21) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 24CBB880; 22) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 24CBT739; 23) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 24CBV226; 24) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 24IBL537; 25) DYKM2187A, UDI-DI: 10195327628826(each), 40195327628827(case), Lot Number: 24JBL006; 26) DYNDH1909A, UDI-DI: 10198459146794(each), 40198459146795(case), Lot Number: 25KME690; 27) DYNDH1909A, UDI-DI: 10198459146794(each), 40198459146795(case), Lot Number: 25AMI449; 28) DYNDH1909A, UDI-DI: 10198459146794(each), 40198459146795(case), Lot Number: 25BMB196; 29) DYNDH1909A, UDI-DI: 10198459146794(each), 40198459146795(case), Lot Number: 25BMI538; 30) DYNDH1909A, UDI-DI: 10198459146794(each), 40198459146795(case), Lot Number: 24JMG337; 31) DYNDH1909A, UDI-DI: 10198459146794(each), 40198459146795(case), Lot Number: 24KMH747; 32) DYNDV1615I, UDI-DI: 10195327407100(each), 40195327407101(case), Lot Number: 24DBM033
Why was this product recalled?
The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination. Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. In rare cases, particularly in critically ill or immunocompromised patients, severe infection could become life-threatening.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Medline Industries, LP take?
An URGENT MEDICAL DEVICE RECALL notification letter dated 6/12/25 was sent to customers. REQUIRED ACTION: 1. Immediately check your stock for the affected item number(s) and the affected lot number(s) listed within the recall portal. Quarantine all affected product. 2. Please use the link and the information below to complete your response form. Please list the quantity of affected product you have in inventory on the form. Even if you do not have any affected product in inventory, please complete and submit the form. Website link: https://recalls.medline.com Recall Reference #: R-26-097-FGX1 Recall Code: 3. Upon receipt of your submitted response form, your account will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. 4. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please include your customers quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product. If you have any questions, contact the Recall Department at 866-359-1704 or [email protected].
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-3056-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology